Accutane – (pending) up to $1+ billion
Written by Andrew Sarski on June 8, 2012
In an action that is still pending, lawsuits filed by 6,634 Accutane patients were consolidated into a mass tort against Hoffman-La Roche, maker of the potentially dangerous acne medication. According to the lawsuit, La Roche produced a defective drug and negligently marketed the product to consumers. The mass tort also alleges that La Roche failed to adequately warn patients about the potential connection between Accutane and serious side effects like inflammatory bowel disease (IBD).